Loading...
XNASSGRY
Market cap2.62bUSD
Jan 10, Last price  
20.65USD
1D
-2.73%
1Q
-32.21%
Jan 2017
30.28%
IPO
12.05%
Name

Surgery Partners Inc

Chart & Performance

D1W1MN
XNAS:SGRY chart
P/E
—
P/S
0.96
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
21.20%
Rev. gr., 5y
9.14%
Revenues
2.74b
+8.03%
260,215,000284,599,000403,289,000959,891,0001,145,438,0001,341,219,0001,771,456,0001,831,400,0001,860,100,0002,225,100,0002,539,300,0002,743,300,000
Net income
-12m
L
1,916,000-9,062,000-65,897,0001,429,0009,453,000-52,985,000-205,706,00046,100,0001,300,00070,700,00087,000,000-11,900,000
CFO
294m
+85.01%
46,377,00049,078,00021,949,00084,481,000125,239,000120,943,000144,600,000129,500,000246,900,00087,100,000158,800,000293,800,000
Earnings
Feb 24, 2025

Profile

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
URL
https://surgerypartners.com/
IPO date
Oct 01, 2015
Employees
9,100
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,743,300
8.03%
2,539,300
14.12%
Cost of revenue
2,216,700
2,066,600
Unusual Expense (Income)
NOPBT
526,600
472,700
NOPBT Margin
19.20%
18.62%
Operating Taxes
300
23,300
Tax Rate
0.06%
4.93%
NOPAT
526,300
449,400
Net income
(11,900)
-113.68%
87,000
23.06%
Dividends
Dividend yield
Proceeds from repurchase of equity
882,900
BB yield
-34.46%
Debt
Debt current
110,900
99,300
Long-term debt
2,569,000
3,138,300
Deferred revenue
Other long-term liabilities
709,300
(16,100)
Net debt
2,299,900
2,764,400
Cash flow
Cash from operating activities
293,800
158,800
CAPEX
(88,800)
(80,600)
Cash from investing activities
(225,600)
(307,900)
Cash from financing activities
(155,200)
42,100
FCF
492,100
129,200
Balance
Cash
195,900
282,900
Long term investments
184,100
190,300
Excess cash
242,835
346,235
Stockholders' equity
864,300
804,900
Invested Capital
6,113,265
5,850,265
ROIC
8.80%
8.12%
ROCE
8.28%
7.52%
EV
Common stock shares outstanding
125,613
91,952
Price
31.99
14.82%
27.86
-47.84%
Market cap
4,018,360
56.86%
2,561,783
-33.78%
EV
7,692,960
6,610,883
EBITDA
644,700
587,500
EV/EBITDA
11.93
11.25
Interest
193,000
234,900
Interest/NOPBT
36.65%
49.69%